Skip to content
Review Open access

Association between glycerol triglyceride glucose-related index and cardiovascular disease in individuals with metabolic dysfunction-associated steatotic liver disease: NHANES 1999–2023

Sep 2026 · Therapeutic Advances in Endocrinology and Metabolism · Vol 19 · 0 citations · 38 references
Medicine

TL;DR

TyG and TyG-WHtR showed positive associations with CVD in patients with MASLD, with a remarkable threshold effect observed for TyG, which are simple auxiliary markers to screen high-risk subgroups during population epidemiological surveys.

Abstract

Background Cardiovascular disease (CVD) is more common in those with metabolic dysfunction-associated steatotic liver disease (MASLD). Although the triglyceride-glucose index (TyG) and its composite indices are straightforward indicators of insulin resistance, it is yet unknown how they relate to the risk of CVD in the MASLD population. Objectives To explore the correlation of TyG and TyG-waist-to-height ratio (TyG-WHtR) with cardiovascular disease risk in the MASLD population. Design This was a population-based cross-sectional study using data from the National Health and Nutrition Examination Survey (NHANES) 1999–2023. Methods Adults with MASLD were included using cross-sectional data from the National Health and Nutrition Examination Survey (NHANES). ROC curve assessments, subgroup analyses, smooth curve fitting, and multivariate logistic regression were carried out. Results Among 1,860 participants, TyG (OR=1.27) and TyG-WHtR (OR=1.20) were independently associated with elevated CVD risk after full covariate adjustment (all P<0.05). TyG exhibited a nonlinear association with CVD risk, with an inflection point at 9.28: below this cutoff, higher TyG was strongly linked to greater CVD risk (OR=2.23, 95% CI: 1.56–3.19), whereas no significant association was detected above the threshold. TyG-WHtR also presented a potential inflection point at 5.54. Stratified analyses revealed stronger associations between both indices and CVD among participants without diabetes, and the magnitude of associations varied across racial subgroups. ROC curve analyses indicated that both markers only achieved modest discriminatory performance for identifying prevalent CVD (AUC: 0.606 for TyG; 0.613 for TyG-WHtR). Conclusion TyG and TyG-WHtR showed positive associations with CVD in patients with MASLD, with a remarkable threshold effect observed for TyG. Both indices are simple auxiliary markers to screen high-risk subgroups during population epidemiological surveys.

Read PDF

Similar papers

Review Open access Jul 2026

Association of triglyceride-glucose (TyG)-Derived inflammatory indices with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: A retrospective cohort study based on NHANES 1999–2018

It is suggested that TyG-derived inflammatory indices may hold clinical value in predicting mortality risk among patients with CKD, and in the first systematic comparison of multiple such indices, TyG-MLR emerged as the best-performing indicator, although its discriminative performance was moderate.

Rong-Wen Lin, Hui-Juan Zhao, Bo Wu · 0 citations
Open access Sep 2026

Association of C-reactive protein-triglycerides-glucose index-waist-to-height ratio with mortality in metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from two cohort studies

MASLD significantly increases the risk of cardiovascular events and all-cause mortality (ACM). The impact of the C-reactive protein-triglyceride-glucose index (CTI) and its derivatives on mortality in the MASLD population remains unclear. This study aimed to investigate their associations with mortality in the MA...

Guang-Jie Tu, Hang Zhai, Jun-Ming Xu et al. · 0 citations
Open access Aug 2026

Metabolic score for insulin resistance is associated with metabolic dysfunction-associated steatotic liver disease among adults with hypertension: a cross-sectional secondary analysis of a Chinese single-center health check-up population

Among adults with hypertension in a Chinese single-center health check-up population, higher METS-IR was associated with a higher likelihood of prevalent MASLD and showed a graded, mildly non-linear pattern.

Feng Lu, L. Qiu, Peng Yu et al. · 0 citations
Aug 2026

Association between visceral adiposity index and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes mellitus: an exploratory cross-sectional study.

Higher VAI values are associated with MASLD in patients with T1DM, however, waist circumference outperforms VAI in identifying MASLD, suggesting that VAI may serve as a complementary marker of metabolic dysfunction rather than a standalone screening tool for MASLD in this patient population.

A. Mantovani, I. Milani, R. Morandin et al. · 0 citations
Open access Aug 2026

Associations between novel triglyceride glucose and adiposity-related indices and risk of metabolic dysfunction-associated steatotic liver disease: the mediating role of biological aging and evidence from the UK Biobank

Background Insulin resistance (IR) plays a critical role in the development and prognosis of metabolic dysfunction-associated steatotic liver disease (MASLD). However, evidence regarding associations between novel triglyceride glucose (TyG) and adiposity-related composite indices, serving as simple IR surrogates, and t...

Kun Wang, Renfang Han, Yueqing Huang et al. · 0 citations
Open access Aug 2026

The cholesterol, high-density lipoprotein, and glucose index and its derived indices predict cardiometabolic multimorbidity development and progression in metabolic dysfunction-associated steatotic liver disease individuals: a prospective cohort study

Among individuals with MASLD, CHG-related indices, particularly CHG-WHtR and CHG-WC, were associated with incident CMM and transition-specific disease progression and improved risk prediction, and readily available indices may help refine CMM risk stratification in MASLD.

K. Mu, Jing Zhang, Shuang Liang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.